What Are Peptides, and Are They Legal? FDA Rules Explained

Peptides are short chains of amino acids, the building blocks of proteins, and some are proven prescription drugs, including the GLP-1 medicines in Ozempic and Wegovy. Others, like BPC-157, have very little human research behind them and have been sold online as "research chemicals." On October 28, 2026, HHS said it will temporarily let licensed pharmacies make six of these peptides for individual patients, but that is not the same as FDA approval.

A peptide is a molecule made of two or more amino acids, according to the National Cancer Institute. When the chain gets long, it is called a polypeptide or a protein.

Your body makes its own peptides, and drug companies have learned to copy and tweak some of them. That is why the word covers everything from carefully tested medicines to vials sold on the internet.

The key point: "peptide" describes the shape of a molecule. It tells you nothing about whether a product is safe, works, or is legal.

Yes. Semaglutide, the drug in Ozempic and Wegovy, is a lab-made version of a natural hormone called glucagon-like peptide-1, or GLP-1. Wegovy's FDA label says its "peptide backbone is produced by yeast fermentation."

The difference is the paper trail. Approved GLP-1 drugs went through large clinical trials and FDA review, and their labels spell out known risks. Many wellness peptides have nothing like that.

The line can blur, too. In August 2026 the FDA warned one online seller for offering semaglutide, tirzepatide and retatrutide labeled for research and "not for human or veterinary use." The FDA said the company's own website showed the products were meant for people.

BPC-157 is a lab-made peptide promoted online for healing injuries. It is often paired with another peptide, TB-500, in what fans call the "Wolverine stack," Reuters reported.

The human evidence is thin. A 2025 review in the HSS Journal found 36 studies of BPC-157 in sports medicine. Thirty-five were in animals or labs. The only human study looked back at 12 people with knee pain. The authors wrote that "clinical safety in humans remains unknown."

Until now, many people bought these peptides on the gray market: websites selling vials stamped "not for human use." In August 2026 the FDA sent warning letters to five such vendors. In one, the agency said selling bacteriostatic water alongside the vials gave buyers "the means to prepare an injectable drug for human administration." The FDA also noted that injections skip some of the body's natural defenses.

If you have a student athlete, know this: BPC-157 is banned in sport under the World Anti-Doping Agency's list, according to the U.S. Anti-Doping Agency.

Compounding pharmacies mix custom drugs for individual patients. By law, they can only use certain ingredients. While the FDA builds its official list, it sorts proposed ingredients into categories. "Category 2" is for substances the agency believes raise significant safety risks.

In 2023 the FDA put 19 peptides in Category 2, including BPC-157, ProPublica reported. For BPC-157, the FDA cited a possible risk of immune reactions, concerns about impurities, and "no, or only limited, safety-related information" for how it is used.

Health Secretary Robert F. Kennedy Jr. has called the 2023 move illegal, arguing the agency acted without first identifying a safety signal.

Here is the short timeline:

The notice was scheduled for the Federal Register on October 30, with two weeks for public comment. HHS says the policy can be revisited "if, among other things, a safety signal or product quality issue arises."

So, is BPC-157 legal? For now, the federal government says it won't act against a licensed pharmacy or doctor making it for a specific patient under these conditions. That is enforcement discretion, not approval. Lawyers at Holland & Knight note that state pharmacy and medical boards are not bound by it. And selling "research use only" vials for people to inject is still treated as a violation by the FDA.

For most of them, nobody knows yet. Compounded drugs are not FDA-approved, so the FDA does not review their safety, effectiveness or quality before they are sold, the HHS notice itself says.

Supporters see the new policy as a safety upgrade. HHS says it will steer people away from research-use peptides made by foreign manufacturers. Lee Rosebush of the American Academy of Peptide Medicine called it a "landmark regulatory milestone."

Skeptics point to the missing evidence. FDA's own reviewers recommended against every peptide the advisory committee considered, according to Holland & Knight. There are practical limits, too: Jeff Cohen of the American Peptide Association told Reuters that states may not follow the federal move.

Healthy, Again. is health news, not medical advice. Talk to your doctor before changing any medicine or supplement.